Novochizol™ overcomes the limitations of chitosan, enhances its existing beneficial properties and displays new characteristics:
- Formulation of all API classes: small molecules, peptides, nucleic acids, proteins, viruses and cells.
- Low viscosity solutions/suspensions under all conditions
- Administration-targeted drug release, without systemic distribution
- Customizable sustained release properties
- Slow biodegradation and physical robustness
- Intracellular delivery of active ingredients, including proteins.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 5, 2023 | A significant number of Swiss biotechs exhibit in Boston | |
| May 23, 2022 | Swiss Biotechs display their innovations at BIO 2022 International Convention |
Reviews 0
FAQ about Novochizol SA
When was Novochizol SA founded?
Novochizol SA was founded in 2021.
What has the press written about Novochizol SA?
Parsers VC has collected 3 articles mentioning Novochizol SA, among them “A significant number of Swiss biotechs exhibit in Boston” (Jun 5, 2023) and “Swiss Biotechs display their innovations at BIO 2022 International Convention” (May 23, 2022).
Is Novochizol SA still active?
Yes, Novochizol SA is active; its latest activity on Parsers VC dates from Aug 8, 2025.